Axel Facius
- Modelling and simulation in successful drug development programmes: Characterisation of exacerbation reduction with roflumilast to corroborate the importance of defining patient subsets in COPDBy Gezim Lahu, Axel Facius, Laurent Claret, Rene Bruno and Dirk BredenbrökerGezim Lahu1Department of Pharmacometrics and Pharmacokinetics, Nycomed GmbH, Konstanz, GermanyAxel Facius1Department of Pharmacometrics and Pharmacokinetics, Nycomed GmbH, Konstanz, GermanyLaurent Claret2Strategic Consulting Services, Pharsight, A Certara™ Company, Marseilles, FranceRene Bruno2Strategic Consulting Services, Pharsight, A Certara™ Company, Marseilles, FranceDirk Bredenbröker3Department of Respiratory Medicine, Nycomed GmbH, Konstanz, Germany
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, and a companion volume of self-assessment questions is available. In 2015, the first ERS Practical Handbook, on Noninvasive Ventilation, was added to the series